APP下载

应用中医药治疗慢性阻塞性肺疾病稳定期虚证研究进展

2020-09-02林照权李昌炳龚年金

中外医学研究 2020年18期
关键词:慢性阻塞性肺疾病稳定期研究进展

林照权 李昌炳 龚年金

【摘要】 慢性阻塞性肺疾病(簡称慢阻肺)是呼吸系统常见病及多发病,是一组气流受限为特征的肺部疾病,气流受限不完全可逆,呈进行性发展,但是可以预防和治疗的疾病。患病率和死亡率均居高不下,因肺功能进行性减退,严重影响患者的劳动力和生活质量,慢阻肺造成巨大的社会和经济负担,根据世界银行及世界卫生组织发表的研究,今年慢阻肺将成为世界疾病经济负担第五位。慢阻肺预防和治疗成为学者们研究的热点,尤其是中医中药治疗在该疾病的预防和治疗起到了显著效果。中医将疾病归纳为“久咳”“肺胀”及“喘证”的范畴,现代医学对于稳定期的患者常采用吸入性糖皮质激素联合长效β2受体激动剂治疗,但西药治疗患者易耐受,且副作用明显。中医治疗讲究辨证论治,治疗以调节患者的免疫机制及微循环,使得患者的症状得以改善,发作次数得以减少,生活质量得以提高。作者通过查阅文献,结合一些临床经验,以中医药理论为基础,对疾病进行病因病机分析及辨证分型治疗予以综述,望为临床治疗提供借鉴。

【关键词】 慢性阻塞性肺疾病 中医药 稳定期 虚症 研究进展

doi:10.14033/j.cnki.cfmr.2020.18.077 文献标识码 A 文章编号 1674-6805(2020)18-0-03

Research Progress of Treatment of Chronic Obstructive Pulmonary Disease Stable Stage Deficiency with Tradition Chinese Medicine/LIN Zhaoquan, LI Changbing, GONG Nianjin. //Chinese and Foreign Medical Research, 2020, 18(18): -188

[Abstract] Chronic obstructive pulmonary disease is a common and frequent disease of respiratory system. It is a group of pulmonary diseases characterized by airflow limitation, which is not completely reversible and progressive, but can be prevented and treated. The prevalence and mortality rate are high, due to the progressive decline of pulmonary function, which seriously affects the workforce and quality of life of patients. Chronic obstructive pulmonary disease causes huge social and economic burden. According to research published by the world bank and the World Health Organization, chronic obstructive pulmonary disease will become the fifth economic burden of disease in the world this year. The prevention and treatment of chronic obstructive pulmonary disease has become a hot topic among scholars, especially the traditional Chinese medicine treatment has played a significant role in the prevention and treatment of the disease. In traditional Chinese medicine, the disease is classified into “chronic cough” “lung distension” and “asthma syndrome”. Modern medicine often uses inhaled glucocorticoid combined with long-acting β2-receptor agonists for patients with stable stage, but western medicine treatment is easy to tolerate, and has obvious side effects. Traditional Chinese medicine treatment pays attention to syndrome differentiation and treatment to regulate the immune mechanism and microcirculation of patients, so that the symptoms of patients can be improved, the number of attacks can be reduced, and the quality of life can be improved. Based on literature review and some clinical experience, the author summarizes the etiology and pathogenesis analysis and syndrome differentiation and classification of diseases on the basis of traditional Chinese medicine theory, hoping to provide reference for clinical treatment.

[Key words] Chronic obstructive pulmonary disease Traditional Chinese medicine Stable stage Deficiency Research progress

First-authors address: Hubei Minzu University, Enshi 445000, China

慢性阻塞性肺疾病简称慢阻肺,确切病因不清楚,认为与肺部对香烟烟雾等有害气体或有害颗粒的异常炎症反应有关。是一种慢性疾病,患者以咳嗽、咳痰、呼吸困难为主要临床症状,出现连续性气……

登录APP查看全文

猜你喜欢

慢性阻塞性肺疾病稳定期研究进展
布地奈德福莫特罗治疗慢阻肺稳定期,慢阻肺合并肺癌稳定期患者的临床疗效
MiRNA-145在消化系统恶性肿瘤中的研究进展
离子束抛光研究进展
独脚金的研究进展
无创正压通气联合参麦注射液治疗COPD并呼吸衰竭的临床效果
多元性护理干预对慢性阻塞性肺疾病长期家庭氧疗依从性的应用价值
无创机械通气联合盐酸氨溴索雾化治疗慢性阻塞性肺疾病伴Ⅱ型呼吸衰竭的效果分析
授权理论在使用无创呼吸机COPD患者健康教育中的应用
EGFR核转位与DNA损伤修复研究进展
舒利迭联合喘可治注射液治疗COPD稳定期的临床疗效观察